top of page

Recent Posts

CRISPR Plus Drug Treatment Makes Neuroblastoma Responsive to Immunotherapy

Oct 29, 2024
1 min read

Researchers in Italy and Australia report a triple combination strategy involving CRISPR that boosts the response of neuroblastoma to immunotherapy.

Read more: https://crisprmedicinenews.com/news/crispr-plus-drug-treatment-makes-neuroblastoma-responsive-to-immunotherapy/

Comments

Cell-free DNA offers early warning for bloodstream infections in kids with leukemia

Posterior Fossa Syndrome Linked to Long-Term Neurocognitive Deficits in Medulloblastoma Survivors

Pesticide Exposure Again Linked to Childhood Acute Lymphoblastic Leukemia, as Rates Rise

Hearing loss contributes to cognitive decline after childhood cancer treatment

Telehealth is Transforming Genetic Care for Childhood Cancer Survivors

Adult Survivors of Childhood Cancer May Do Well With Simple Strategy for CV Risk

New research reveals how subtle genetic differences shape neuroblastoma behaviour

Addressing Alienation Can Improve Psychosocial Outcomes in Pediatric Cancer

Discovery of unique brain tumor subtypes offers hope for targeted glioma therapies

New registry analysis links three-year childhood cancer survival to stage at diagnosis

Archive

Search By Tags

bottom of page